The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Recent News
PharmaVoice: Behind the breakthrough cancer therapy that just won a historic FDA nod
Article Link: https://www.pharmavoice.com/news/fda-iovance-til-solid-tumor-cell-therapy/707988/
Fox 26 News: FDA approves cell therapy to treat melanoma
Article Link: https://www.fox26houston.com/video/1413925
The Washington Post: Cancer therapy approved by FDA uses body’s own cells as a ‘living drug’
Article Link: https://www.washingtonpost.com/business/2024/02/20/fda-cancer-cell-therapy/
European Pharmaceutical Review: Novel immunotherapy approved for melanoma
Article Link: https://www.europeanpharmaceuticalreview.com/news/212486/novel-immunotherapy-approved-for-melanoma/
Reuter: US FDA grants accelerated approval for Iovance’s skin cancer cell therapy
Article Link:...
FDA Greenlights Lifileucel for Unresectable, Metastatic Melanoma Via Accelerated Approval
Article Link: https://www.cgtlive.com/view/fda-lifileucel-amtagvi-unresectable-metastatic-melanoma-accelerated-approval
BioSpace: FDA Approves First One-time Cell Therapy for a Solid Tumor
Article Link: https://www.biospace.com/article/an-fda-approval-for-iovance-could-jumpstart-40-year-old-field-/
Empowered Patient Podcast with Karen Jagoda
Special guests: Dr. Christopher Flowers, MD Anderson Cancer Center and Dr. Jason Bock, CTMC Article Link:...
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Article Link:...